by Sowmya Viswanathan | Jun 26, 2018
Debe Griffin, MSc, ASQ CPGP, has over 20 years of experience in the cell therapy field, both in bench positions and in leadership. Her primary interests are process improvement, quality assurance and regulatory affairs. She is a consultant with FACT Consulting...
by Stacey Johnson | Mar 23, 2018
With 570 stem cell clinics in the United States alone offering direct-to-consumer marketing of stem cell interventions and “clear grounds for concern that some of the companies we found are not compliant with federal regulations” (Knoepfler and Turner, Cell Stem...
by David Kent | Jan 22, 2018
Over the Christmas break, I finally got around to reading an article that has been in my “to read” pile for far too long. For anybody new to the regenerative medicine and cellular therapy fields, it is an absolutely fantastic resource to catch up on some of the...
by Stacey Johnson | Jun 16, 2017
Understanding cell therapy regulation is an essential component of the bench to bedside pipeline. Without approval from a country’s regulator (Health Canada, FDA, EMA, PMDA, etc.), a product cannot be sold to consumers and the millions invested in research and...
Comments